BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.84B |
| 2 |
Apple
AAPL
|
+$1.98B |
| 3 |
NVIDIA
NVDA
|
+$1.94B |
| 4 |
Amazon
AMZN
|
+$1.5B |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$1.22B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.61B |
| 2 |
Merck
MRK
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$309M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$227M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$199M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.57% |
| 2 | Consumer Discretionary | 8.06% |
| 3 | Financials | 7.49% |
| 4 | Healthcare | 6.58% |
| 5 | Communication Services | 5.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4751
Landmark Bancorp
LARK
$196M
| $29.3K | ﹤0.01% |
1,120
-38
| -3% | -$995 |
|
4752
iShares MSCI Switzerland ETF
EWL
$2.21B
| $29.2K | ﹤0.01% |
487
-200
| -29% | -$11.5K |
|
4753
Inseego
INSG
$77M
| $29.2K | ﹤0.01% |
2,839
+131
| +5% | +$1.7K |
|
4754
Lifezone Metals
LZM
$356M
| $29.1K | ﹤0.01% |
6,805
+1,682
| +33% | +$7.6K |
|
|
OBAWW
4755
Oxley Bridge Acquisition Ltd Warrants
OBAWW
$2.78M
| $29K | ﹤0.01% |
+131,819
| New | +$32.6K |
|
4756
SEACOR Marine Holdings
SMHI
$268M
| $28.9K | ﹤0.01% |
4,803
+841
| +21% | +$5.56K |
|
4757
Fate Therapeutics
FATE
$300M
| $28.8K | ﹤0.01% |
29,295
+1,939
| +7% | +$2.33K |
|
4758
Anixa Biosciences
ANIX
$108M
| $28.5K | ﹤0.01% |
+9,140
| New | +$37.4K |
|
|
AMBQ
4759
Ambiq Micro
AMBQ
$1.56B
| $28.2K | ﹤0.01% |
989
+49
| +5% | +$1.4K |
|
|
VWAV
4760
VisionWave Holdings
VWAV
$52.7M
| $28.1K | ﹤0.01% |
+3,035
| New | +$31.6K |
|
|
INACR
4761
Indigo Acquisition Corp Right
INACR
| $28.1K | ﹤0.01% |
+216,090
| New | +$37.7K |
|
4762
PetMed Express
PETS
$38.9M
| $28.1K | ﹤0.01% |
8,778
-287
| -3% | -$720 |
|
|
TOUR
4763
Tuniu
TOUR
$53.2M
| $28.1K | ﹤0.01% |
4,526
+979
| +28% | +$7.71K |
|
4764
Hanover Bancorp
HNVR
$194M
| $28K | ﹤0.01% |
1,212
-77
| -6% | -$1.72K |
|
4765
Pyxis Oncology
PYXS
$191M
| $27.9K | ﹤0.01% |
24,279
+22,562
| +1,314% | +$79.6K |
|
4766
The Joint Corp
JYNT
$120M
| $27.8K | ﹤0.01% |
3,183
+248
| +8% | +$2.1K |
|
4767
BlackRock TCP Capital
TCPC
$342M
| $27.7K | ﹤0.01% |
+5,072
| New | +$29.2K |
|
4768
SR Bancorp
SRBK
$146M
| $27.4K | ﹤0.01% |
1,742
-611
| -26% | -$9.37K |
|
4769
Clarus
CLAR
$140M
| $27.1K | ﹤0.01% |
8,088
+1,862
| +30% | +$6.34K |
|
4770
Verastem
VSTM
$596M
| $27.1K | ﹤0.01% |
3,507
-5,043
| -59% | -$44.9K |
|
4771
Nuveen Credit Strategies Income Fund
JQC
$708M
| $27.1K | ﹤0.01% |
5,392
-5,731
| -52% | -$29.1K |
|
4772
Global Water Resources
GWRS
$247M
| $27.1K | ﹤0.01% |
3,202
-1,551
| -33% | -$14.6K |
|
4773
Forafric Global
AFRI
$286M
| $27K | ﹤0.01% |
2,445
+502
| +26% | +$4.87K |
|
|
QSEAR
4774
Quartzsea Acquisition Corp Rights
QSEAR
| $26.9K | ﹤0.01% |
+119,661
| New | +$30.8K |
|
4775
Nuvectis Pharma
NVCT
$618M
| $26.7K | ﹤0.01% |
3,541
+743
| +27% | +$4.84K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2025 Portfolio in Review
As of Q4 2025, BNP Paribas Financial Markets held 6,035 positions worth $221B, up 18% from $187B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $25.1B of net new capital in Q4 2025, opening 491 new positions and adding to 2,632 existing holdings. Its largest new stake was Iris Energy: 4,201,138 shares worth $159M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $1.61B trimmed.
- BNP Paribas Financial Markets's largest Q4 2025 buy was Iris Energy: 4,201,138 shares worth $159M.
- BNP Paribas Financial Markets added most to Microsoft in Q4 2025, an estimated $2.84B increase.
- BNP Paribas Financial Markets's biggest Q4 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.61B.
- BNP Paribas Financial Markets fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $41M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $221B portfolio in Q4 2025.
- BNP Paribas Financial Markets opened 491 new positions and closed 305 in Q4 2025.
- BNP Paribas Financial Markets's portfolio value rose 18% quarter-over-quarter to $221B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2025, filed 10 Feb 2026.